CVE-2026-66875: Quanovate Tech Inc. (operating as Mira / Mira Care) Mira Firmware · Missing Authentication
Affects Quanovate Tech Inc. (operating as Mira / Mira Care) Mira FirmwareSource CVE Database V5
Not known to be exploited · CVSS 8.7 High.
Data as of 9 Nov 2026, 23:24 UTC
- EPSS
- 0.4% chance of exploitation in 30 days – higher than 35% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
CVSS:4.0/AV:A/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:N/SI:N/SA:NExploitation evidence
Disclosed: evidence found.
CVE published 11 Aug 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 10 Nov 2026.
What to do
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Quanovate Tech Inc. (operating as Mira / Mira Care)Mira Firmware | Affected
| Fixed in– |
| Quanovate Tech Inc. (operating as Mira / Mira Care)Mira Android App | Affected
| Fixed in– |
AI-suggested
Until a fix is available, users should limit BLE exposure by disabling Bluetooth when not in use and avoid using the device in untrusted environments. Monitor vendor communications for updates on official patches or mitigations.
Description
In the Mira hormone monitor device firmware v1.7.1.47 build 01070147, a remote unauthenticated attacker within BLE range (approximately 10–30 meters) can silently rebind the device to an attacker-controlled account, extract stored hormone measurements in cleartext, cause a denial-of-service via malformed or undocumented command opcodes, and passively track the user via a static random BLE address that never rotates.